NCT06390059
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06390059
Title EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NovoCure GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | DEU | CZE | CHE

Facility Status City State Zip Country Details
University Hospital Hradec Kralove Hradec Králové 500 05 Czechia Details
University Hospital Olomouc Olomouc 779 00 Czechia Details
University Hospital Motol Prague 150 06 Czechia Details
University Hospital Bulovka Prague 180 81 Czechia Details
Asklepios Hospital Altona Hamburg 22763 Germany Details
University Hospital Tuebingen Tübingen 72076 Germany Details
University Hospital Ulm Ulm 89081 Germany Details
University Hospital Vall d'Hebron Barcelona 08035 Spain Details
University General Hospital Gregorio Maranon Madrid 28007 Spain Details
University Hospital Foundation Jimenez Diaz Madrid 28040 Spain Details
Clara Campal Comprehensive Cancer Center (CIOCC) Madrid 28050 Spain Details
Regional University Hospital of Malaga Málaga 29010 Spain Details
University Clinic of Navarra - Pamplona Pamplona 31008 Spain Details
Inselspital, University Hospital Bern Bern 3010 Switzerland Details
Fribourg Cantonal Hospital, Internal Medicine and Oncology Fribourg 1708 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field